Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024

BUY
$21.39 - $49.64 $566,856 - $1.32 Million
26,501 New
26,501 $1.22 Million
Q2 2023

Jul 27, 2023

BUY
$16.32 - $21.15 $215,228 - $278,926
13,188 New
13,188 $217,000
Q2 2022

Aug 09, 2022

BUY
$3.12 - $12.25 $70,717 - $277,658
22,666 New
22,666 $94,000
Q2 2018

Jul 30, 2018

SELL
$17.02 - $35.2 $110,647 - $228,835
-6,501 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$17.02 - $35.2 $110,647 - $228,835
6,501 New
6,501 $203,000

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.73B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.